Nanomedicine can kill tumor cells or block the growth and spread of cancers by maximizing drug accumulation in tumor tissues. How much drug will selectively accumulate in tumor tissues depends on physical parameters such as vessel permeability in tumor microenvironments. On the other hand, by properly choosing the size of nanomedicine, the accumulation of drugs in normal tissues will be reduced. In this study, we measured the permeability rate of vessels in different strain of mice in vivo with two-photon fluorescent angiography. We used FITC / TRITC / TEXAS RED labeled dextran to investigate size-dependent permeation from vessels in normal tissues. We choose nanoparticles of 40kDa, 70 kDa, 150 kDa and 2000 kDa, and selected three strains of wild-type Balb/C, ICR, C2J mice. We found , even at the same size, the vascular permeability rate of dextran still vary with the dye-conjugates and the strain of mice. One of our results shows that ICR mice have the biggest vessel hole in normal tissues. Choosing wrong nanoparticle size will cause their leaking in normal tissues. This study will provide a new threshold and guideline to reduce the accumulation of nanomedicine in normal tissues.
Lin-Jie Lin, Pei-Chun Wu, and Tzu-Ming Liu, "The effect of mice strain and labeling on the interstitial vessel permeability of nanoparticles (Conference Presentation)," Proc. SPIE 10475, Visualizing and Quantifying Drug Distribution in Tissue II, 1047506 (Presented at SPIE BiOS: January 27, 2018; Published: 14 March 2018); https://doi.org/10.1117/12.2288776.5751468299001.
Conference Presentations are recordings of oral presentations given at SPIE conferences and are published as part of the conference proceedings. They include the speaker's narration along with video of the slides and animations. Most also include full-text papers. Interactive, searchable transcripts and closed captioning are now available for 2018 presentations, with transcripts for prior recordings added daily.
Search and browse our growing collection of more than 16,000 conference presentations, including many plenary and keynote presentations.